• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型口服活性多巴胺前药N-(N-乙酰-L-甲硫氨酰)-O,O-双(乙氧羰基)多巴胺(TA-870)与盐酸多巴胺在大鼠和犬体内处置的比较研究。

Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.

作者信息

Yoshikawa M, Endo H, Otsuka M, Yamaguchi I, Harigaya S

机构信息

Biological Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.

出版信息

Drug Metab Dispos. 1988 Sep-Oct;16(5):754-8.

PMID:2906602
Abstract

The pharmacokinetics of a dopamine derivative, TA-870, and dopamine (DA) after oral administration are compared in rats and dogs. The maximum concentrations of free DA in plasma after oral administration of TA-870 were 150 ng/ml in the rat (30 mg/kg) and 234 ng/ml in the dog (33.5 mg/kg). On the contrary, the maximum plasma concentrations after oral administration of DA at an equimolar dose to TA-870 were 12 ng/ml in the rat (12 mg/kg) and 36 ng/ml in the dog (13.5 mg/kg). The AUC values of free DA in plasma after oral administration of TA-870 (30 or 33.5 mg/kg) were 4-6 times higher than those after DA in both animal species. The peak tissue levels of radioactivity in rats after oral administration of [14C]TA-870 (30 mg/kg) were also 5.5 times higher in the liver and 1-2 times higher in other tissues than those after [14C]DA dose (12 mg/kg). In rats, the main excretion route of radioactivity after oral administration of [14C]TA-870 or DA was via the urine. The total recoveries of radioactivity in the urine and feces were 91-96% of the dose within 24 hr for both compounds. Biliary excretion in rats accounted for 19.8% of the dose of [14C]TA-870 and 12.6% of the dose of [14C]DA within 24 hr. These results demonstrate that TA-870 was well absorbed from the digestive tract, extensively metabolized to dopamine, and proved to be an orally usable dopamine prodrug.

摘要

在大鼠和狗中比较了多巴胺衍生物TA - 870和多巴胺(DA)口服给药后的药代动力学。口服TA - 870后,大鼠(30mg/kg)血浆中游离DA的最大浓度为150ng/ml,狗(33.5mg/kg)为234ng/ml。相反,以与TA - 870等摩尔剂量口服DA后,大鼠(12mg/kg)血浆最大浓度为12ng/ml,狗(13.5mg/kg)为36ng/ml。在两种动物中,口服TA - 870(30或33.5mg/kg)后血浆中游离DA的AUC值比口服DA后高4 - 6倍。口服[¹⁴C]TA - 870(30mg/kg)后,大鼠肝脏中放射性的峰值组织水平也比口服[¹⁴C]DA剂量(12mg/kg)后高5.5倍,其他组织中高1 - 2倍。在大鼠中,口服[¹⁴C]TA - 870或DA后放射性的主要排泄途径是通过尿液。两种化合物在24小时内尿液和粪便中放射性的总回收率为给药剂量的91 - 96%。大鼠胆汁排泄在24小时内占[¹⁴C]TA - 870剂量的19.8%,占[¹⁴C]DA剂量的12.6%。这些结果表明,TA - 870从消化道吸收良好,广泛代谢为多巴胺,并被证明是一种可口服的多巴胺前药。

相似文献

1
Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.新型口服活性多巴胺前药N-(N-乙酰-L-甲硫氨酰)-O,O-双(乙氧羰基)多巴胺(TA-870)与盐酸多巴胺在大鼠和犬体内处置的比较研究。
Drug Metab Dispos. 1988 Sep-Oct;16(5):754-8.
2
First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs.新型口服活性多巴胺前药N-(N-乙酰基-L-甲硫氨酰基)-O,O-双(乙氧羰基)多巴胺在犬体内的首过代谢及体外代谢
Drug Metab Dispos. 1991 Sep-Oct;19(5):960-5.
3
Disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl) dopamine (TA-870) in humans.
Drug Metab Dispos. 1990 Mar-Apr;18(2):212-7.
4
Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.新型血管紧张素转换酶抑制剂咪达普利在动物体内的代谢命运。首次通讯:在大鼠和犬体内的吸收、药代动力学及排泄
Arzneimittelforschung. 1992 Apr;42(4):457-65.
5
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
6
A novel orally active dopamine prodrug TA-870. I. Renal and cardiovascular effects and plasma levels of free dopamine in dogs and rats.一种新型口服活性多巴胺前药TA - 870。I. 对犬和大鼠的肾脏、心血管作用及游离多巴胺的血浆水平
J Cardiovasc Pharmacol. 1989 Jun;13(6):879-86. doi: 10.1097/00005344-198906000-00010.
7
Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs.新型口服活性多巴胺前药N-(N-乙酰-L-甲硫氨酰)-O,O-双(乙氧羰基)多巴胺(TA-870)及多巴胺在大鼠和犬口服给药后的代谢
J Pharmacobiodyn. 1990 Apr;13(4):246-53. doi: 10.1248/bpb1978.13.246.
8
Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.尼莫地平的药代动力学。I. 通讯:大鼠、狗和猴单次给予[14C]尼莫地平后的吸收、血浆浓度及排泄
Arzneimittelforschung. 1985;35(12):1781-6.
9
Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.尼索地平的药代动力学。I. 大鼠、狗、猴和猪单次给予[14C]尼索地平后的吸收、血浆浓度及排泄
Arzneimittelforschung. 1988 Aug;38(8):1093-8.
10
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.新型促甲状腺素释放激素类似物水合蒙替瑞林的药代动力学。首次通讯:对大鼠、狗和猴子单次静脉给药后的血浆浓度、代谢及排泄情况
Arzneimittelforschung. 1996 Feb;46(2):106-13.

引用本文的文献

1
Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.签收、密封、送达:共轭和前药策略作为抗生素的靶向递送载体
ACS Infect Dis. 2019 Jun 14;5(6):816-828. doi: 10.1021/acsinfecdis.9b00019. Epub 2019 Apr 10.